mdl 73404 has been researched along with mdl 74270 in 1 studies
Studies (mdl 73404) | Trials (mdl 73404) | Recent Studies (post-2010) (mdl 73404) | Studies (mdl 74270) | Trials (mdl 74270) | Recent Studies (post-2010) (mdl 74270) |
---|---|---|---|---|---|
20 | 0 | 0 | 5 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bolkenius, FN; De Jong, W; Dow, J; Grisar, JM; Haegele, KD; Petty, MA; Wagner, ER; Wagner, J | 1 |
1 other study(ies) available for mdl 73404 and mdl 74270
Article | Year |
---|---|
A cardioselective, hydrophilic N,N,N-trimethylethanaminium alpha-tocopherol analogue that reduces myocardial infarct size.
Topics: Animals; Benzopyrans; Brain; Cardiovascular Agents; Free Radical Scavengers; Indicators and Reagents; Lipid Peroxidation; Molecular Structure; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Structure-Activity Relationship; Tissue Distribution; Vitamin E | 1991 |